Senti Biosciences Holdings, Inc. (SNTI)
NASDAQ: SNTI · Real-Time Price · USD
0.955
-0.105 (-9.88%)
At close: Apr 28, 2026, 4:00 PM EDT
0.950
-0.005 (-0.56%)
After-hours: Apr 28, 2026, 7:38 PM EDT
SNTI Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 0.02 | - | 2.56 | 4.29 | 2.76 | |
| Revenue Growth (YoY) | - | - | -40.25% | 55.23% | 387.81% | |
| Cost of Revenue | 37.59 | 34.36 | 32.15 | 28.15 | 21.96 | |
| Gross Profit | -37.56 | -34.36 | -29.59 | -23.86 | -19.2 | |
| Selling, General & Admin | 20.74 | 19.92 | 34.85 | 38.23 | 21.25 | |
| Operating Expenses | 20.74 | 19.92 | 34.85 | 38.23 | 21.25 | |
| Operating Income | -58.3 | -54.28 | -64.44 | -62.08 | -40.45 | |
| Interest & Investment Income | 0.93 | 0.95 | 2.86 | 1.7 | 0.01 | |
| Other Non Operating Income (Expenses) | 0.99 | 18.07 | 3.3 | -0.03 | -0.12 | |
| EBT Excluding Unusual Items | -56.39 | -35.26 | -58.28 | -60.42 | -40.56 | |
| Asset Writedown | -5.05 | -0.31 | -25.96 | - | -0.02 | |
| Other Unusual Items | - | -17.22 | 0.83 | 10.75 | -14.74 | |
| Pretax Income | -61.44 | -52.79 | -83.41 | -49.67 | -55.32 | |
| Earnings From Continuing Operations | -61.44 | -52.79 | -83.41 | -49.67 | -55.32 | |
| Earnings From Discontinued Operations | - | - | 12.35 | -8.55 | - | |
| Net Income | -61.44 | -52.79 | -71.06 | -58.21 | -55.32 | |
| Preferred Dividends & Other Adjustments | - | 2.52 | - | - | - | |
| Net Income to Common | -61.44 | -55.31 | -71.06 | -58.21 | -55.32 | |
| Shares Outstanding (Basic) | 22 | 5 | 4 | 3 | 0 | |
| Shares Outstanding (Diluted) | 22 | 5 | 4 | 3 | 0 | |
| Shares Change (YoY) | 389.20% | 3.58% | 69.93% | 796.58% | -78.99% | |
| EPS (Basic) | -2.73 | -12.03 | -16.01 | -22.29 | -189.95 | |
| EPS (Diluted) | -2.73 | -12.03 | -16.01 | -22.29 | -189.95 | |
| Free Cash Flow | -43.64 | -41.42 | -64.43 | -76.27 | -40.18 | |
| Free Cash Flow Per Share | -1.94 | -9.01 | -14.52 | -29.21 | -137.96 | |
| Operating Margin | -265018.18% | - | -2516.28% | -1448.53% | -1464.90% | |
| Profit Margin | -279263.64% | - | -2774.62% | -1358.14% | -2003.59% | |
| Free Cash Flow Margin | -198363.64% | - | -2515.93% | -1779.51% | -1455.20% | |
| EBITDA | -54.67 | -50.44 | -60.88 | -60.69 | -39.68 | |
| D&A For EBITDA | 3.64 | 3.84 | 3.56 | 1.4 | 0.77 | |
| EBIT | -58.3 | -54.28 | -64.44 | -62.08 | -40.45 | |
| Revenue as Reported | - | - | 2.56 | 4.29 | 2.76 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.